RxSight expects to sell 4,000,000 shares of its common stock at a price to the public of $12.50 per share.
The revenue growth as compared to the fourth quarter of 2020, was due to a 96% increase in the number of LDDs sold and 88% increase...
The company seeks to improve the vision of patients following cataract surgery.
Get the most important news and business ideas for eyecare professionals every weekday from INVISION.
Advertisement